FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3209224483> ?p ?o ?g. }

• W3209224483 endingPage "4861" @default.
• W3209224483 startingPage "4861" @default.
• W3209224483 abstract "Juvenile idiopathic arthritis (JIA) is the most common inflammatory chronic disease affecting children and adolescents. Today, there are no specific biomarkers of inflammation. Therefore, it is important to identify new markers as predictors of disease activity. Recently, some researchers have directed their interest toward a protein, calprotectin (CLP), as a potential biomarker. The primary objective of our systematic review and meta-analysis was to analyze the possible role of CLP in JIA.A literature search was conducted using PubMed, EMBASE, Scopus, Science Direct on 10 August 2021. The selection of studies was made using the PRISMA 2020 guidelines. Cohen's d with 95% CI and p-value were used as a measure of effect size. The random effects model was used to account for different sources of variation among studies. Heterogeneity was assessed using Q statistics and I2. The publication bias was analyzed and represented by a funnel plot, and funnel plot symmetry was assessed with Egger's test.Our results at follow-up showed a statistically significant difference between patients with active disease compared to patients with inactive disease: 0.39 (0.16; 0.62), p = 0.001; without statistical heterogeneity. Another important aspect that emerged were the differences between the systemic disease form and any form of inactive disease showing a different concentration of calprotectin: 0.74 (0.40; 1.08), p < 0.001; without statistical heterogeneity. On the other hand, meta-regression analyses performed on gender, age, duration of disease, percentage of patients with ANA+ or RF+, medium value of ESR or CRP were not statistically significant. A statistically significant difference in serum calprotectin concentration between patients with JIA and healthy controls were observed. In fact, it presented lower values in the control group.The use of serum CLP could represent, in the future, a useful tool in JIA in order to stratify disease activity more accurately and may aid a more tailored approach to drug of choice in children with JIA. Further studies are needed to evaluate CLP as a predictor of flare in combination with other potential biomarkers of subclinical disease activity." @default.
• W3209224483 created "2021-11-08" @default.
• W3209224483 creator A5010575503 @default.
• W3209224483 creator A5020725873 @default.
• W3209224483 creator A5024671243 @default.
• W3209224483 creator A5054367640 @default.
• W3209224483 creator A5077451775 @default.
• W3209224483 creator A5077717610 @default.
• W3209224483 creator A5089282003 @default.
• W3209224483 date "2021-10-22" @default.
• W3209224483 modified "2023-10-18" @default.
• W3209224483 title "Serum Calprotectin a Potential Biomarker in Juvenile Idiopathic Arthritis: A Meta-Analysis" @default.
• W3209224483 cites W1537972189 @default.
• W3209224483 cites W1976624818 @default.
• W3209224483 cites W1986755404 @default.
• W3209224483 cites W2020615358 @default.
• W3209224483 cites W2044992731 @default.
• W3209224483 cites W2062152303 @default.
• W3209224483 cites W2072063489 @default.
• W3209224483 cites W2075591761 @default.
• W3209224483 cites W2076961991 @default.
• W3209224483 cites W2078206110 @default.
• W3209224483 cites W2095518569 @default.
• W3209224483 cites W2108561804 @default.
• W3209224483 cites W2118217628 @default.
• W3209224483 cites W2119041703 @default.
• W3209224483 cites W2125430925 @default.
• W3209224483 cites W2154552358 @default.
• W3209224483 cites W2157823046 @default.
• W3209224483 cites W2161750455 @default.
• W3209224483 cites W2166421281 @default.
• W3209224483 cites W2211059366 @default.
• W3209224483 cites W2394576713 @default.
• W3209224483 cites W2501949584 @default.
• W3209224483 cites W2530165096 @default.
• W3209224483 cites W2599726068 @default.
• W3209224483 cites W2610981692 @default.
• W3209224483 cites W2890590901 @default.
• W3209224483 cites W2999701574 @default.
• W3209224483 cites W3013762813 @default.
• W3209224483 cites W3082102065 @default.
• W3209224483 cites W3141256924 @default.
• W3209224483 cites W3170447017 @default.
• W3209224483 cites W3185051823 @default.
• W3209224483 cites W3159429896 @default.
• W3209224483 doi "https://doi.org/10.3390/jcm10214861" @default.
• W3209224483 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/8584429" @default.
• W3209224483 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34768386" @default.
• W3209224483 hasPublicationYear "2021" @default.
• W3209224483 type Work @default.
• W3209224483 sameAs 3209224483 @default.
• W3209224483 citedByCount "3" @default.
• W3209224483 countsByYear W32092244832021 @default.
• W3209224483 countsByYear W32092244832022 @default.
• W3209224483 countsByYear W32092244832023 @default.
• W3209224483 crossrefType "journal-article" @default.
• W3209224483 hasAuthorship W3209224483A5010575503 @default.
• W3209224483 hasAuthorship W3209224483A5020725873 @default.
• W3209224483 hasAuthorship W3209224483A5024671243 @default.
• W3209224483 hasAuthorship W3209224483A5054367640 @default.
• W3209224483 hasAuthorship W3209224483A5077451775 @default.
• W3209224483 hasAuthorship W3209224483A5077717610 @default.
• W3209224483 hasAuthorship W3209224483A5089282003 @default.
• W3209224483 hasBestOaLocation W32092244831 @default.
• W3209224483 hasConcept C126322002 @default.
• W3209224483 hasConcept C143998085 @default.
• W3209224483 hasConcept C2777077863 @default.
• W3209224483 hasConcept C2778260677 @default.
• W3209224483 hasConcept C2778292693 @default.
• W3209224483 hasConcept C2779134260 @default.
• W3209224483 hasConcept C2780439572 @default.
• W3209224483 hasConcept C2781197716 @default.
• W3209224483 hasConcept C55493867 @default.
• W3209224483 hasConcept C71924100 @default.
• W3209224483 hasConcept C82605166 @default.
• W3209224483 hasConcept C86803240 @default.
• W3209224483 hasConcept C95190672 @default.
• W3209224483 hasConceptScore W3209224483C126322002 @default.
• W3209224483 hasConceptScore W3209224483C143998085 @default.
• W3209224483 hasConceptScore W3209224483C2777077863 @default.
• W3209224483 hasConceptScore W3209224483C2778260677 @default.
• W3209224483 hasConceptScore W3209224483C2778292693 @default.
• W3209224483 hasConceptScore W3209224483C2779134260 @default.
• W3209224483 hasConceptScore W3209224483C2780439572 @default.
• W3209224483 hasConceptScore W3209224483C2781197716 @default.
• W3209224483 hasConceptScore W3209224483C55493867 @default.
• W3209224483 hasConceptScore W3209224483C71924100 @default.
• W3209224483 hasConceptScore W3209224483C82605166 @default.
• W3209224483 hasConceptScore W3209224483C86803240 @default.
• W3209224483 hasConceptScore W3209224483C95190672 @default.
• W3209224483 hasIssue "21" @default.
• W3209224483 hasLocation W32092244831 @default.
• W3209224483 hasLocation W32092244832 @default.
• W3209224483 hasLocation W32092244833 @default.
• W3209224483 hasLocation W32092244834 @default.
• W3209224483 hasLocation W32092244835 @default.
• W3209224483 hasOpenAccess W3209224483 @default.
• W3209224483 hasPrimaryLocation W32092244831 @default.

• next